Fig. 3From: The association of MEFV gene mutations with the disease risk and severity of systemic juvenile idiopathic arthritisComparison of a average duration of use of each drug, b the relative period of activity, c relative relapse rate among the no mutation group, the one mutation group and the more than one mutation groupBack to article page